| Literature DB >> 33489013 |
Susana Benet1,2, Cristina Gálvez1,2, Francis Drobniewski3, Irina Kontsevaya3,4,5, Lilibeth Arias6,7,8, Marta Monguió-Tortajada9,10,11, Itziar Erkizia1, Victor Urrea1, Ruo-Yan Ong12, Marina Luquin7, Maeva Dupont13,14, Jakub Chojnacki1, Judith Dalmau1, Paula Cardona6,7,8, Olivier Neyrolles13,14, Geanncarlo Lugo-Villarino13,14, Christel Vérollet13,14, Esther Julián7, Hansjakob Furrer15, Huldrych F Günthard16,17, Paul R Crocker12, Gustavo Tapia2,18,19, Francesc E Borràs9,20, Jacques Fellay21,22,23, Paul J McLaren24,25, Amalio Telenti26, Pere-Joan Cardona6,7,8, Bonaventura Clotet1,19,27, Cristina Vilaplana6,7,8, Javier Martinez-Picado1,19,27,28, Nuria Izquierdo-Useros1,19.
Abstract
The identification of individuals with null alleles enables studying how the loss of gene function affects infection. We previously described a non-functional variant in SIGLEC1, which encodes the myeloid-cell receptor Siglec-1/CD169 implicated in HIV-1 cell-to-cell transmission. Here we report a significant association between the SIGLEC1 null variant and extrapulmonary dissemination of Mycobacterium tuberculosis (Mtb) in two clinical cohorts comprising 6,256 individuals. Local spread of bacteria within the lung is apparent in Mtb-infected Siglec-1 knockout mice which, despite having similar bacterial load, developed more extensive lesions compared to wild type mice. We find that Siglec-1 is necessary to induce antigen presentation through extracellular vesicle uptake. We postulate that lack of Siglec-1 delays the onset of protective immunity against Mtb by limiting antigen exchange via extracellular vesicles, allowing for an early local spread of mycobacteria that increases the risk for extrapulmonary dissemination.Entities:
Keywords: Extracellular vesicles; HIV‐1; Mtb; Siglec‐1
Mesh:
Substances:
Year: 2021 PMID: 33489013 PMCID: PMC7807485 DOI: 10.1002/jev2.12046
Source DB: PubMed Journal: J Extracell Vesicles ISSN: 2001-3078